Complera Lawsuit

Lawsuits recently filed charge Gilead Sciences, the maker of widely-prescribed class of HIV medications that includes Complera, with bringing a defective drug to market, and of unnecessarily exposing the public to a risk of serious side effects when there are a variety of safer, less dangerous HIV drugs available.

Free Confidential Lawsuit Evaluation: If you or a loved one has been harmed by the side effects of Complera or another tenofovir-containing HIV medication, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against Gilead Sciences and our lawyers can help.

Update: Judge Clears Suit Alleging Gilead HIV Medications Defectively Designed

May 11, 2019 – U.S. District Judge Jon S. Tigar has greenlighted a lawsuit filed by a group of patients accusing Gilead Sciences Inc. of negligence, products liability, and a host of other allegations surrounding its tenofovir disoproxil fumarate- containing HIV drugs, but agreed to narrow the scope of the case by tossing allegations that Gilead hid knowledge that the medicines are “unreasonably and unnecessarily unsafe.” Tigar cleared various other claims made in the suit, including design defect, negligence and product liability claims.

What is Complera?

Complera combines the drugs Truvada (generic: emtricitabine and tenofovir disoproxil fumarate) and Edurant (rilpivirine) for a complete once-a-day HIV-1 treatment. The drug is made by Gilead Sciences, and was approved by the U.S. Food & Drug Administration (FDA) in August 2011.

Complera Dosage

The recommended dosage of COMPLERA in adults and children at least 35 kg (77 lbs.) is one tablet taken orally once daily with food, according to Gilead Sciences.

What’s the Problem?

One recently-filed lawsuit claims that HIV patients suffered from up to a decade of “additional accumulated kidney and bone toxicity” from tenofovir disoproxil fumarate, an ingredient in Complera and its other HIV drugs, while the manufacturer withheld an equally effective yet safer product from the public. Lawyers claim that Gilead knew that their HIV drugs had to be given in high doses to be effective, which meant they could damage the kidneys and bones, yet the company failed to adequately warn patients or doctors about those side effects on the medicine’s label. Gilead is now urging doctors to switch their patients to the new drugs to reduce possible harm to their kidneys and bones.

Complera Side Effects

Bone demineralization
Loss of bone density
Bone fractures
Osteopenia
Osteoporosis
Kidney damage
Kidney toxicity
Chronic kidney disease (CKD)
Kidney failure (renal failure)
And more

Which Other HIV Medications Have Been Linked to These Side Effects?

In addition to Complera, other HIV drugs that may cause the above side effects include:

Can I File a Suit?

Only a qualified attorney can determine whether you are eligible to file a lawsuit against Gilead Sciences, the maker of Complera, which is why we are currently offering free case evaluations. Simply fill out the confidential evaluation form below to contact our law firm now.

Most cases involving pharmaceuticals allege that a drug was sold with design, manufacturing, and/or marketing defects, which typically refers to a company’s failure to warn of a certain side effect. In the case of Complera, our attorneys suspect that patients may be able to take legal action in light of claims that Gilead failed to adequately warn doctors and patients about the risk of bone fractures and kidney damage.

Do I have a Complera Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Complera lawsuits. We are handling individual litigation nationwide and currently accepting new kidney injury and bone fracture cases in all 50 states.

Free Case Evaluation: Again, if you suffered a bone fracture / break, or had any kidney problems after taking Complera, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.